Social value of statins merits actions to broaden treatment, improve adherence, study finds
News
Article
New evidence suggests that statins generate large survival and health benefits at the population level and shows that the social value of the survival gains are large and go predominantly to consumers, according to a study published in the October issue of Health Affairs.
Social value of statins merits actions to broaden treatment, improve adherence, study finds
New evidence suggests that statins generate large survival and health benefits at the population level and shows that the social value of the survival gains are large and go predominantly to consumers, according to a study published in the October issue of Health Affairs.
FDA Approves Imaavy for Long Term Treatment of Generalized Myasthenia Gravis
Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.
Read More
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Read More
Oncologists: Prior Authorizations Lead to Delays in Getting Cancer Meds
Insurance hurdles and the complexities of prior authorization create barriers to care, according to oncologists in a new survey by Sermo.
Read More
Novo Nordisk Offers Wegovy Through Telehealth Providers, Including Hims & Hers
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg through its NovoCare Pharmacy.
Read More
Food Retailer Giant Eagle Selects EmpiRx Health as PBM
Giant Eagle also helped EmpiRx Health create a national pharmacy care network that was purpose-built for pharmacy and grocery chains.
Read More
Part D Plans Cover a Larger Share of Medicare Beneficiaries in Rural Counties
Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.
Read More
FDA Approves Imaavy for Long Term Treatment of Generalized Myasthenia Gravis
Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.
Read More
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Read More
Oncologists: Prior Authorizations Lead to Delays in Getting Cancer Meds
Insurance hurdles and the complexities of prior authorization create barriers to care, according to oncologists in a new survey by Sermo.
Read More
Novo Nordisk Offers Wegovy Through Telehealth Providers, Including Hims & Hers
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg through its NovoCare Pharmacy.
Read More
Food Retailer Giant Eagle Selects EmpiRx Health as PBM
Giant Eagle also helped EmpiRx Health create a national pharmacy care network that was purpose-built for pharmacy and grocery chains.
Read More
Part D Plans Cover a Larger Share of Medicare Beneficiaries in Rural Counties
Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.
Read More